Sanofi uses SCM for radiolabelled production
Sanofi-Aventis is using SCM Pharma’s aseptic fill/finish service for radiolabelled compounds to manufacture an oncology product that is in clinical trials.
Sanofi-Aventis is using SCM Pharma’s aseptic fill/finish service for radiolabelled compounds to manufacture an oncology product that is in clinical trials.
The United Arab Emirates (UAE) is looking to establish itself as a prime location for pharmaceutical companies, with “massive amounts of money and huge incentives” being used to attract business.
MDS Pharma Services posted an 18 per cent drop in revenue in its Q2 results, which also contained details of restructuring that will affect 180 people and cost $4m (€2.8m).
Germany’s IQWiG has accused US drugmaker Pfizer of “concealing data on the effect of a drug Edronax for the treatment of depression.”
Industry response to the H1N1 pandemic suggests that cell culture vaccine production is about to come of age with two firms that use the technique, Novartis and Baxter, claiming it will cut development and manufacturing timelines by months.